Atezolizumab-bevacizumab and Other Immunotherapies: Real-life Experience for Treatment of Hepatocellular Carcinoma
NCT06806579
·
clinicaltrials.gov ↗
RECRUITING
Status
1000
Enrollment
OTHER
Sponsor class
Conditions
Hepatocellular Carcinoma (HCC)
Sponsor
IRCCS Azienda Ospedaliero-Universitaria di Bologna